Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on June 1, 2025

Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …

TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health
LOS ANGELES, June 01, 2025 (GLOBE NEWSWIRE) -- As global temperatures continue to rise and daily comfort becomes a growing concern, TORRAS is making waves with its innovative Coolify series—a wearable air conditioner engineered to deliver rapid, personal …

Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML
– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of adult …

CERE 截止日期為週二:全國審判法律顧問 ROSEN 鼓勵損失超過 10 萬美元的 Cerevel Therapeutics Holdings, Inc. 投資者在證券集體訴訟的重要截止日期 6 月 3 日之前聘請律師 - CERE
紐約, June 02, 2025 (GLOBE NEWSWIRE) -- 事由:全球投資者權益律師事務所 Rosen Law Firm 提醒個人或實體:(1) 在 2023 年 10 月 11 日至 2024 年 8 月 1 日(含)期間(「集體訴訟期」)出售或以其他方式處置 Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) 的公開交易普通股;(2) 自 2024 年 1 月 8 日登記日起持有 Cerevel 股份,並有權就 Cerevel 與 …

CERE DEADLINE TUESDAY: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) …

RCAT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Red Cat Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

VTRS DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – VTRS
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of …

VTRS 截止日期提醒:資深投資人法律顧問 ROSEN 鼓勵損失超過 10 萬美元的 Viatris Inc. 投資人於 6 月 3 日證券集體訴訟重要截止日期前聘請律師 - VTRS
紐約, June 02, 2025 (GLOBE NEWSWIRE) -- 事由:全球投資人權益律師事務所 Rosen Law Firm 提醒在 2024 年 8 月 8 日至 2025 年 2 月 26 日(含首尾兩天,簡稱「集體訴訟期間」)期間購買 Viatris Inc. (NASDAQ: VTRS) 股票的人士,2025 年 6 月 3 日是重要的首席原告截止日期。 影響:如果您在集體訴訟期間購買了 Viatris 股票,您可能有權透過後酬約定獲得賠償而無需支付任何自付費用或成本。 …

RCAT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Red Cat Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, June 01, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman …

TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TechTarget, Inc. (NASDAQ: TTGT) resulting from allegations that …

Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
Data Highlights Transformative Promise of CAR T in Solid Tumors Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved a 31% …

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
New York, NY, June 01, 2025 (GLOBE NEWSWIRE) -- As the 2025 wedding season approaches, EKOUAER is proud to unveil its Wedding Season Special Edition campaign, running from June 1 to August 31, 2025. Centered around the theme “EKOUAER Wedding Season Special …

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were …

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ZBIO
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus ( …

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Digimarc Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMRC
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period …

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay to accelerate analysis and reduce costs, making large- …

Best SEO Tool (June 2025): Moz Named Top SEO Software by Software Experts
NEW YORK CITY, June 01, 2025 (GLOBE NEWSWIRE) -- Software Experts has recognized Moz as the Best SEO Tool of June 2025, highlighting the platform’s continued leadership in delivering accessible, data-driven tools for modern SEO strategy. The recognition …

Li Auto Inc. May 2025 Delivery Update
BEIJING, China, June 01, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 40,856 vehicles in May 2025, representing a year-over- …

ROSEN, REGARDED INVESTOR COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NSSC
NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the …